12:27 PM
 | 
Apr 16, 2018
 |  BC Extra  |  Politics & Policy

China to exempt cancer drugs from tariffs, at a potential cost to industry

The China State Council announced April 12 that the country will exempt all cancer drugs from import tariffs, beginning on May 1. The imported cancer drugs and other "innovative drugs" will be incorporated into the China's National Reimbursement Drug List, which may mean...

Read the full 193 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >